# A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

> **NCT02833610** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 55 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Denosumab Q4W

## Key facts

- **NCT ID:** NCT02833610
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-03-20
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02833610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02833610, "A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02833610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*